Corteva, Inc. $CTVA Holdings Lowered by Janus Henderson Group PLC

Janus Henderson Group PLC trimmed its stake in shares of Corteva, Inc. (NYSE:CTVA) by 29.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,608,236 shares of the company’s stock after selling 3,132,619 shares during the period. Janus Henderson Group PLC owned about 1.13% of Corteva worth $509,983,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the third quarter valued at $25,000. Bank of Jackson Hole Trust purchased a new stake in Corteva in the 4th quarter worth about $28,000. Redmont Wealth Advisors LLC purchased a new stake in Corteva in the 3rd quarter worth about $29,000. Cornerstone Financial Management LLC purchased a new stake in Corteva in the 4th quarter worth about $29,000. Finally, Basepoint Wealth LLC purchased a new stake in Corteva in the 4th quarter worth about $30,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Up 0.7%

CTVA opened at $77.45 on Thursday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The business has a 50-day moving average of $79.88 and a 200-day moving average of $75.59. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company has a market capitalization of $51.80 billion, a PE ratio of 45.56, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period last year, the business earned $1.13 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 42.35%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CTVA. Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Berenberg Bank increased their price objective on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Wells Fargo & Company increased their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Finally, BNP Paribas Exane increased their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.